The Effectiveness of a Succinate-Containing Medication in Accompanying Therapy of Comorbid Tuberculosis in a Penitentiary Institution

The aim of the study was to analyze the features of the organization of therapy for patients with HIV-associated tuberculosis (TB/HIV) and the effectiveness of pharmacotherapeutic approaches under the conditions of penitentiary institutions. Materials and methods: the data on the incidence and effectiveness of specialized medical care for TB/HIV patients were analyzed for a ten-year period in the population of penitentiary institutions of the Federal Penitentiary Service of one of the subjects of the Central Federal District of the Russian Federation. Therapy and examination of patients with TB/HIV was carried out in accordance with regulatory documents and using generally accepted diagnostic methods. The patients consulted the staff of the departments of the FSBEI HE KSMU to verify the diagnosis and correct treatment regimens. Results: the analysis showed that, despite the stabilization of the TB epidemic situation, the epidemiological indicators for comorbid TB/HIV are increasing in the penitentiary health sector, which is due to an increase in the number of HIV-infected patients. In order to intensify the treatment of patients with TB/HIV in the population of the penitentiary system, it is necessary to give priority to social and sanitary prevention, primarily in risk groups — HIV-infected and individuals with residual lung changes. The inclusion of Remaxol in the therapy regimens for TB/HIV patients promotes rapid relief of hepatotoxic reactions and, as a consequence, increases the effectiveness of the primary therapy, which is illustrated by clinical observation.

1. Vasil-eva I. A., Sterlikov S. A., Belilovskij E. M., Borisov S. E., Ponomarev S. B. Tuberkulez v uchrezhdeniyakh ugolovno-ispolnitel-noj sistemy v stranakh Evropy i v Rossijskoj Federatsii. Tuberkulez i Bolezni Legkikh 2018; 96 (5): 6–13. doi 10.21292/2075-1230-2018-96-5-6-13 [in Russian]

2. Ravil-one M., Korobitsin A. A. Likvidatsiya tuberkuleza — novaya strategiya VOZ v eru ustojchivogo razvitiya, vklad Rossijskoj Federatsii. Tuberkulez i Bolezni Legkikh 2016; 11: 8–15.

3. TB/VICh v Rossijskoj Federatsii. Epidemiologiya, osobennosti klinicheskikh proyavlenij i rezul-taty lecheniya. Pod red. S.A. Sterlikova. M.: RIO TsNIIOIZ, 2018; 67. [in Russian]

4. Kolomiets V.M. Penitentsiarnyj tuberkulez: patomorfoz i effektivnost- reabilitatsii. Kursk: FGBOU VO KGMU Minzdrava Rossii, 2014; 248. [in Russian]

5. Zagdyn Z.M. VICh/tuberkulez v mestakh lisheniya svobody na Severo-Zapade Rossii. Sovremennye Problemy Zdravookhraneniya i Meditsinskoj Statistiki 2019; 1: 123–143. DOI: 10.24411/2312-2935-2019-10008 [in Russian]

6. Kolomiets V.M., Medvedeva N.N. Kliniko-psikholoshicheskie osobennosti u bol-nykh razlichnymi formami tuberkuleza legkikh. Tuberkulez i Sotsial-no Znachimye Zabolevaniya 2019; 1: 79–80. [in Russian]

7. Balasanyants G.S. Gepatotoksicheskie rektsii i gepatoprpotektivnaya terapiya vo ftiziatrii. Tuberkulez i Bolezni Legkikh 2015; 8: 48–50. [in Russian]

8. Pavlova M.V., Ershova E.S., Chernokhaeva I.V., Sapozhnikova N.V., Archakova L.I. Nezhelatel-nye reaktsii pri lechenii tuberkuleza organov dykhaniya preparatami novogo pokoleniya. Meditsinskij Al-yans 2018; 2: 23–27. [in Russian]

9. Ivanova D. A., Borisov S. E. Spektr i faktory riska nezhelatel-nykh pobochnykh reaktsij pri lechenii vpervye vyyavlennykh bol-nykh tuberkulezom. Tuberkulez i Bolezni Legkikh 2017; 95 (6): 22–29. DOI: 10.21292/2075-1230-2017-95-6-22-29 [in Russian]

10. Vol-f S.B. Nezhelatel-nye pobochnye reaktsii na khimioterapijyu tuberkuleza. Zhurnal Grodnenskogo Gosudarstvennogo Meditsinskogo Universiteta 2016; 3: 140–146. [in Russian]

11. Matievskaya N.V., Prokopchik N.I., Tsyrkunov V.M. Patomorfologicheskie osobennosti porazheniya pecheni pri koinfektsii Tuberkulez/VICh. Zhurnal Grodnenskogo Gosudarstvennogo Meditsinskogo Universiteta 2012; 1: 66–69. [in Russian]

12. Ivanov A.K.Koretskaya N.M., Elyart V.F. Gepatoprotektornaya terapiya u bol-nykh tuberkulezom v penitentsiarnom uchrezhdenii. Meditsinskuij Al-yans 2015; 1: 98–101. [in Russian]

13. Ushkareva E.V. Kliniko-ekonomicheskaya effektivnost- ispol-zovaniya remaksola v lechenii infil-trativnogo tuberkuleza legkikh. Vestnik Ural-skoj Meditsinskoj Akademicheskoj Nauki 2016; 4: 61–64. doi: 10.22138/2500-0918-2016-14-4-61-64 [in Russian]

14. Sundukov A.V., Mel-nikov L. V., Alikeeva G. K., Vdovina E. T., Safiullina N. Kh. Gepatoprotektivnaya terapiya pri diffuznykh porazheniyakh pecheni u VICh-infitsirovannykh bol-nykh. Eksperimental-naya i Klinicheskaya Gastroenterologiya 2018; 5 (153): 112–116. [in Russian]